David Herrington to Antihypertensive Agents
This is a "connection" page, showing publications David Herrington has written about Antihypertensive Agents.
Connection Strength
0.650
-
O'Neal WT, Soliman EZ, Qureshi W, Alonso A, Heckbert SR, Herrington D. Sustained pre-hypertensive blood pressure and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis. J Am Soc Hypertens. 2015 Mar; 9(3):191-6.
Score: 0.358
-
Mellen PB, Herrington DM. Pharmacogenomics of blood pressure response to antihypertensive treatment. J Hypertens. 2005 Jul; 23(7):1311-25.
Score: 0.185
-
Mohler ER, Herrington D, Ouyang P, Mangano C, Ritter S, Davis P, Purkayastha D, Gatlin M, Vogel RA. A randomized, double-blind trial comparing the effects of amlodipine besylate/benazepril HCl vs amlodipine on endothelial function and blood pressure. J Clin Hypertens (Greenwich). 2006 Oct; 8(10):692-8.
Score: 0.050
-
Mirzai S, Volk MC, Kazibwe R, Gabani M, Schaich CL, Hammonds R, Seals A, Singleton MJ, Yeboah J, Shapiro MD, Herrington D, Kitzman DW, Hughes TM, Williamson JD, Kritchevsky SB. Association of Gait Speed With Cognitive Outcomes in Older Adults With Hypertension: A Secondary SPRINT MIND Analysis. J Aging Phys Act. 2025 Oct 01; 33(5):439-447.
Score: 0.045
-
Hindorff LA, Heckbert SR, Psaty BM, Lumley T, Siscovick DS, Herrington DM, Edwards KL, Tracy RP. beta(2)-Adrenergic receptor polymorphisms and determinants of cardiovascular risk: the Cardiovascular Health Study. Am J Hypertens. 2005 Mar; 18(3):392-7.
Score: 0.011